About Cordis S.A.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Cordis S.A.
During the past decade, Cordis S.A. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 8 clinical trials were completed, i.e. on
average, 266.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Sacral Nerve Stimulation for Anal Incontinence and Bowel Control
1998-11-01
2012-09-01
Completed
140
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
2005-11-01
Unknown status
120
Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium
2006-01-01
2008-01-01
Terminated
60
A Study With Pentasa in Patients With Active Crohn's Disease
2009-04-01
2010-10-01
Terminated
20
Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy
2009-12-01
2014-02-01
Withdrawn
98
Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
2009-09-01
2017-08-01
Completed
51
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Cordis S.A."
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Cordis S.A.
According to Clinical.Site data, the most researched conditions in "Cordis S.A." are
"Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Lupus Erythematosus, Systemic" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Cordis S.A." in a lesser frequency.
Clinical Trials Intervention Types at Cordis S.A.
Most popular intervention types in "Cordis S.A." are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Atacicept 150 mg" (2 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Atacicept 75 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cordis S.A.
The vast majority of trials in "Cordis S.A." are
8 trials for "All" genders.
Clinical Trials Status at Cordis S.A.
Currently, there are NaN active trials in "Cordis S.A.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Cordis S.A.,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Cordis S.A., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".